AI assistant
Relay Therapeutics, Inc. — Director's Dealing 2021
Mar 27, 2021
32320_dirs_2021-03-26_5db4bb3c-5d13-44aa-bff5-ae9600c32d98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2021-03-26
Reporting Person: Bergstrom Donald A (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-26 | Common Stock | A | 34999 | $0.00 | Acquired | 133565 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-26 | Stock Option (Right to Buy) | $34.25 | A | 69998 | Acquired | 2031-03-25 | Common Stock (69998) | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments after March 26, 2021, subject to the reporting person's continued service with the Issuer through each vesting date.
F2: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after March 26, 2021, subject to the reporting person's continued service with the Issuer through each vesting date.